Homing and engraftment of progenitor cells: A prerequisite for cell therapy

This publication has 74 references indexed in Scilit:

• Getting to the site of inflammation: the leukocyte adhesion cascade updated
  Nature Reviews Immunology, 2007
• Mesenchymal Stem Cells Use Integrin β1 Not CXC Chemokine Receptor 4 for Myocardial Migration and Engraftment
  Molecular Biology of the Cell, 2007
• PSGL-1–mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells
  Journal of Clinical Investigation, 2007
• Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo
  PLOS ONE, 2007
• Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α
  Journal of Clinical Investigation, 2007
• CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration
  Blood, 2006
• Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy
  Proceedings of the National Academy of Sciences, 2006
• Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction
  Proceedings of the National Academy of Sciences, 2006
• Functional disruption of α4 integrin mobilizes bone marrow–derived endothelial progenitors and augments ischemic neovascularization
  The Journal of Experimental Medicine, 2006
• Integrins
  Cell, 2002